Role of B-Type Natriuretic Peptide and Effect of Nesiritide After Total Cardiac Replacement With the AbioCor Total Artificial Heart
Endogenous B-type natriuretic peptide (BNP) is thought to be produced in the cardiac ventricles. After sub-total cardiectomy and implantation of a total artificial heart (TAH), the abrupt withdrawal of BNP impairs renal function despite normal hemodynamic variables. We hypothesized that abrupt withd...
Gespeichert in:
| Veröffentlicht in: | The Journal of heart and lung transplantation 2005-08, Vol.24 (8), p.1166-1170 |
|---|---|
| Hauptverfasser: | , , , , , , , , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | 1170 |
|---|---|
| container_issue | 8 |
| container_start_page | 1166 |
| container_title | The Journal of heart and lung transplantation |
| container_volume | 24 |
| creator | Delgado, Reynolds Wadia, Yasmin Kar, Biswajit Ethridge, Whitson Zewail, Aly Pool, Toni Myers, Timothy J. Scroggins, Nancy Frazier, O.H. |
| description | Endogenous B-type natriuretic peptide (BNP) is thought to be produced in the cardiac ventricles. After sub-total cardiectomy and implantation of a total artificial heart (TAH), the abrupt withdrawal of BNP impairs renal function despite normal hemodynamic variables. We hypothesized that abrupt withdrawal of endogenous BNP may impair renal function and volume homeostasis and BNP may have a direct renal influence unrelated to its cardiovascular effect. Nesiritide infusion should be supplemented in the interim and weaned slowly until BNP levels normalize, which suggests that BNP is produced in tissues other than the cardiac ventricles. |
| doi_str_mv | 10.1016/j.healun.2004.10.008 |
| format | Article |
| fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_68490734</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S1053249804005534</els_id><sourcerecordid>68490734</sourcerecordid><originalsourceid>FETCH-LOGICAL-c390t-cb5cac57a748e99f61ded510c430e2abf0c5d6fb113485c06066b3f9387a59b23</originalsourceid><addsrcrecordid>eNp9kU2LFDEQQIMo7rr6D0Ry0VuPlc5Hd1-EcVhdYVllGfEY0ukKk6Gn0yZpYc_-cTPOyN48VVH1qiheEfKawYoBU-_3qx2acZlWNYAopRVA-4RcMimbijPWPC05SF7VomsvyIuU9gBQc1k_JxdMMaiFai7J7_swIg2Ofqy2DzPSO5OjXyJmb-k3nLMfkJppoNfOoc1H8A6Tj_5vY-0yRroN2Yx0Y-LgjaX3OI_G4gGnTH_4vKN5V8Deh034h65j9s5bX9IbNDG_JM-cGRO-Oscr8v3T9XZzU91-_fxls76tLO8gV7aX1ljZmEa02HVOsQEHycAKDlib3oGVg3I9Y1y00oICpXruOt42RnZ9za_Iu9PeOYafC6asDz5ZHEczYViSVq3ooOGigOIE2hhSiuj0HP3BxAfNQB_l670-yddH-cdqkV_G3pz3L_0Bh8ehs-0CvD0DJlkzumgm69Mj14DiUvDCfThxWGz88hh1sh4ni4OP5Qt6CP7_l_wBevCkqA</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>68490734</pqid></control><display><type>article</type><title>Role of B-Type Natriuretic Peptide and Effect of Nesiritide After Total Cardiac Replacement With the AbioCor Total Artificial Heart</title><source>MEDLINE</source><source>ScienceDirect Journals (5 years ago - present)</source><creator>Delgado, Reynolds ; Wadia, Yasmin ; Kar, Biswajit ; Ethridge, Whitson ; Zewail, Aly ; Pool, Toni ; Myers, Timothy J. ; Scroggins, Nancy ; Frazier, O.H.</creator><creatorcontrib>Delgado, Reynolds ; Wadia, Yasmin ; Kar, Biswajit ; Ethridge, Whitson ; Zewail, Aly ; Pool, Toni ; Myers, Timothy J. ; Scroggins, Nancy ; Frazier, O.H.</creatorcontrib><description>Endogenous B-type natriuretic peptide (BNP) is thought to be produced in the cardiac ventricles. After sub-total cardiectomy and implantation of a total artificial heart (TAH), the abrupt withdrawal of BNP impairs renal function despite normal hemodynamic variables. We hypothesized that abrupt withdrawal of endogenous BNP may impair renal function and volume homeostasis and BNP may have a direct renal influence unrelated to its cardiovascular effect. Nesiritide infusion should be supplemented in the interim and weaned slowly until BNP levels normalize, which suggests that BNP is produced in tissues other than the cardiac ventricles.</description><identifier>ISSN: 1053-2498</identifier><identifier>EISSN: 1557-3117</identifier><identifier>DOI: 10.1016/j.healun.2004.10.008</identifier><identifier>PMID: 16102467</identifier><language>eng</language><publisher>New York, NY: Elsevier Inc</publisher><subject>Acute Kidney Injury - diagnosis ; Acute Kidney Injury - drug therapy ; Aged ; Biological and medical sciences ; Biomarkers - analysis ; Dose-Response Relationship, Drug ; Drug Administration Schedule ; Follow-Up Studies ; Heart Failure - diagnosis ; Heart Failure - surgery ; Heart, Artificial - adverse effects ; Humans ; Infusions, Intravenous ; Male ; Medical sciences ; Middle Aged ; Natriuretic Peptide, Brain - administration & dosage ; Natriuretic Peptides - analysis ; Natriuretic Peptides - metabolism ; Risk Assessment ; Sampling Studies ; Severity of Illness Index ; Surgery (general aspects). Transplantations, organ and tissue grafts. Graft diseases ; Surgery of the heart ; Treatment Outcome</subject><ispartof>The Journal of heart and lung transplantation, 2005-08, Vol.24 (8), p.1166-1170</ispartof><rights>2005 International Society for Heart and Lung Transplantation</rights><rights>2005 INIST-CNRS</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c390t-cb5cac57a748e99f61ded510c430e2abf0c5d6fb113485c06066b3f9387a59b23</citedby><cites>FETCH-LOGICAL-c390t-cb5cac57a748e99f61ded510c430e2abf0c5d6fb113485c06066b3f9387a59b23</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://dx.doi.org/10.1016/j.healun.2004.10.008$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>314,780,784,3548,27923,27924,45994</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=17063543$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/16102467$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Delgado, Reynolds</creatorcontrib><creatorcontrib>Wadia, Yasmin</creatorcontrib><creatorcontrib>Kar, Biswajit</creatorcontrib><creatorcontrib>Ethridge, Whitson</creatorcontrib><creatorcontrib>Zewail, Aly</creatorcontrib><creatorcontrib>Pool, Toni</creatorcontrib><creatorcontrib>Myers, Timothy J.</creatorcontrib><creatorcontrib>Scroggins, Nancy</creatorcontrib><creatorcontrib>Frazier, O.H.</creatorcontrib><title>Role of B-Type Natriuretic Peptide and Effect of Nesiritide After Total Cardiac Replacement With the AbioCor Total Artificial Heart</title><title>The Journal of heart and lung transplantation</title><addtitle>J Heart Lung Transplant</addtitle><description>Endogenous B-type natriuretic peptide (BNP) is thought to be produced in the cardiac ventricles. After sub-total cardiectomy and implantation of a total artificial heart (TAH), the abrupt withdrawal of BNP impairs renal function despite normal hemodynamic variables. We hypothesized that abrupt withdrawal of endogenous BNP may impair renal function and volume homeostasis and BNP may have a direct renal influence unrelated to its cardiovascular effect. Nesiritide infusion should be supplemented in the interim and weaned slowly until BNP levels normalize, which suggests that BNP is produced in tissues other than the cardiac ventricles.</description><subject>Acute Kidney Injury - diagnosis</subject><subject>Acute Kidney Injury - drug therapy</subject><subject>Aged</subject><subject>Biological and medical sciences</subject><subject>Biomarkers - analysis</subject><subject>Dose-Response Relationship, Drug</subject><subject>Drug Administration Schedule</subject><subject>Follow-Up Studies</subject><subject>Heart Failure - diagnosis</subject><subject>Heart Failure - surgery</subject><subject>Heart, Artificial - adverse effects</subject><subject>Humans</subject><subject>Infusions, Intravenous</subject><subject>Male</subject><subject>Medical sciences</subject><subject>Middle Aged</subject><subject>Natriuretic Peptide, Brain - administration & dosage</subject><subject>Natriuretic Peptides - analysis</subject><subject>Natriuretic Peptides - metabolism</subject><subject>Risk Assessment</subject><subject>Sampling Studies</subject><subject>Severity of Illness Index</subject><subject>Surgery (general aspects). Transplantations, organ and tissue grafts. Graft diseases</subject><subject>Surgery of the heart</subject><subject>Treatment Outcome</subject><issn>1053-2498</issn><issn>1557-3117</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2005</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp9kU2LFDEQQIMo7rr6D0Ry0VuPlc5Hd1-EcVhdYVllGfEY0ukKk6Gn0yZpYc_-cTPOyN48VVH1qiheEfKawYoBU-_3qx2acZlWNYAopRVA-4RcMimbijPWPC05SF7VomsvyIuU9gBQc1k_JxdMMaiFai7J7_swIg2Ofqy2DzPSO5OjXyJmb-k3nLMfkJppoNfOoc1H8A6Tj_5vY-0yRroN2Yx0Y-LgjaX3OI_G4gGnTH_4vKN5V8Deh034h65j9s5bX9IbNDG_JM-cGRO-Oscr8v3T9XZzU91-_fxls76tLO8gV7aX1ljZmEa02HVOsQEHycAKDlib3oGVg3I9Y1y00oICpXruOt42RnZ9za_Iu9PeOYafC6asDz5ZHEczYViSVq3ooOGigOIE2hhSiuj0HP3BxAfNQB_l670-yddH-cdqkV_G3pz3L_0Bh8ehs-0CvD0DJlkzumgm69Mj14DiUvDCfThxWGz88hh1sh4ni4OP5Qt6CP7_l_wBevCkqA</recordid><startdate>20050801</startdate><enddate>20050801</enddate><creator>Delgado, Reynolds</creator><creator>Wadia, Yasmin</creator><creator>Kar, Biswajit</creator><creator>Ethridge, Whitson</creator><creator>Zewail, Aly</creator><creator>Pool, Toni</creator><creator>Myers, Timothy J.</creator><creator>Scroggins, Nancy</creator><creator>Frazier, O.H.</creator><general>Elsevier Inc</general><general>Elsevier Science</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>20050801</creationdate><title>Role of B-Type Natriuretic Peptide and Effect of Nesiritide After Total Cardiac Replacement With the AbioCor Total Artificial Heart</title><author>Delgado, Reynolds ; Wadia, Yasmin ; Kar, Biswajit ; Ethridge, Whitson ; Zewail, Aly ; Pool, Toni ; Myers, Timothy J. ; Scroggins, Nancy ; Frazier, O.H.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c390t-cb5cac57a748e99f61ded510c430e2abf0c5d6fb113485c06066b3f9387a59b23</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2005</creationdate><topic>Acute Kidney Injury - diagnosis</topic><topic>Acute Kidney Injury - drug therapy</topic><topic>Aged</topic><topic>Biological and medical sciences</topic><topic>Biomarkers - analysis</topic><topic>Dose-Response Relationship, Drug</topic><topic>Drug Administration Schedule</topic><topic>Follow-Up Studies</topic><topic>Heart Failure - diagnosis</topic><topic>Heart Failure - surgery</topic><topic>Heart, Artificial - adverse effects</topic><topic>Humans</topic><topic>Infusions, Intravenous</topic><topic>Male</topic><topic>Medical sciences</topic><topic>Middle Aged</topic><topic>Natriuretic Peptide, Brain - administration & dosage</topic><topic>Natriuretic Peptides - analysis</topic><topic>Natriuretic Peptides - metabolism</topic><topic>Risk Assessment</topic><topic>Sampling Studies</topic><topic>Severity of Illness Index</topic><topic>Surgery (general aspects). Transplantations, organ and tissue grafts. Graft diseases</topic><topic>Surgery of the heart</topic><topic>Treatment Outcome</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Delgado, Reynolds</creatorcontrib><creatorcontrib>Wadia, Yasmin</creatorcontrib><creatorcontrib>Kar, Biswajit</creatorcontrib><creatorcontrib>Ethridge, Whitson</creatorcontrib><creatorcontrib>Zewail, Aly</creatorcontrib><creatorcontrib>Pool, Toni</creatorcontrib><creatorcontrib>Myers, Timothy J.</creatorcontrib><creatorcontrib>Scroggins, Nancy</creatorcontrib><creatorcontrib>Frazier, O.H.</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>The Journal of heart and lung transplantation</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Delgado, Reynolds</au><au>Wadia, Yasmin</au><au>Kar, Biswajit</au><au>Ethridge, Whitson</au><au>Zewail, Aly</au><au>Pool, Toni</au><au>Myers, Timothy J.</au><au>Scroggins, Nancy</au><au>Frazier, O.H.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Role of B-Type Natriuretic Peptide and Effect of Nesiritide After Total Cardiac Replacement With the AbioCor Total Artificial Heart</atitle><jtitle>The Journal of heart and lung transplantation</jtitle><addtitle>J Heart Lung Transplant</addtitle><date>2005-08-01</date><risdate>2005</risdate><volume>24</volume><issue>8</issue><spage>1166</spage><epage>1170</epage><pages>1166-1170</pages><issn>1053-2498</issn><eissn>1557-3117</eissn><abstract>Endogenous B-type natriuretic peptide (BNP) is thought to be produced in the cardiac ventricles. After sub-total cardiectomy and implantation of a total artificial heart (TAH), the abrupt withdrawal of BNP impairs renal function despite normal hemodynamic variables. We hypothesized that abrupt withdrawal of endogenous BNP may impair renal function and volume homeostasis and BNP may have a direct renal influence unrelated to its cardiovascular effect. Nesiritide infusion should be supplemented in the interim and weaned slowly until BNP levels normalize, which suggests that BNP is produced in tissues other than the cardiac ventricles.</abstract><cop>New York, NY</cop><pub>Elsevier Inc</pub><pmid>16102467</pmid><doi>10.1016/j.healun.2004.10.008</doi><tpages>5</tpages></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 1053-2498 |
| ispartof | The Journal of heart and lung transplantation, 2005-08, Vol.24 (8), p.1166-1170 |
| issn | 1053-2498 1557-3117 |
| language | eng |
| recordid | cdi_proquest_miscellaneous_68490734 |
| source | MEDLINE; ScienceDirect Journals (5 years ago - present) |
| subjects | Acute Kidney Injury - diagnosis Acute Kidney Injury - drug therapy Aged Biological and medical sciences Biomarkers - analysis Dose-Response Relationship, Drug Drug Administration Schedule Follow-Up Studies Heart Failure - diagnosis Heart Failure - surgery Heart, Artificial - adverse effects Humans Infusions, Intravenous Male Medical sciences Middle Aged Natriuretic Peptide, Brain - administration & dosage Natriuretic Peptides - analysis Natriuretic Peptides - metabolism Risk Assessment Sampling Studies Severity of Illness Index Surgery (general aspects). Transplantations, organ and tissue grafts. Graft diseases Surgery of the heart Treatment Outcome |
| title | Role of B-Type Natriuretic Peptide and Effect of Nesiritide After Total Cardiac Replacement With the AbioCor Total Artificial Heart |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-12T14%3A57%3A56IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Role%20of%20B-Type%20Natriuretic%20Peptide%20and%20Effect%20of%20Nesiritide%20After%20Total%20Cardiac%20Replacement%20With%20the%20AbioCor%20Total%20Artificial%20Heart&rft.jtitle=The%20Journal%20of%20heart%20and%20lung%20transplantation&rft.au=Delgado,%20Reynolds&rft.date=2005-08-01&rft.volume=24&rft.issue=8&rft.spage=1166&rft.epage=1170&rft.pages=1166-1170&rft.issn=1053-2498&rft.eissn=1557-3117&rft_id=info:doi/10.1016/j.healun.2004.10.008&rft_dat=%3Cproquest_cross%3E68490734%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=68490734&rft_id=info:pmid/16102467&rft_els_id=S1053249804005534&rfr_iscdi=true |